KG
Therapeutic Areas
Atrium Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ATR 1072 | PRKAG2 (Protein Kinase AMP-activated non-catalytic subunit Gamma 2) Syndrome | Pre-clinical |
| ATR 1086 | PLN (Phospholamban) Cardiomyopathy | Pre-clinical |
| Undisclosed Research Target 1 | Rare Cardiomyopathy | Research |
| Undisclosed Research Target 2 | Rare Cardiomyopathy | Research |